In conclusion, we demonstrate that miR-9 overexpression sensitizes HCC cells to cisplatin by inhibiting EIF5A2 and preventing EMT, which sheds light on the mechanisms of miR-9 regulation of HCC chemosensitivity and provides a novel target for improving chemotherapy efficiency in HCC. This evidence concerns the gene EIF5A2 and hepatocellular carcinoma.